Yvonne Hui Sells 744 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) insider Yvonne Hui sold 744 shares of Phreesia stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $23.25, for a total value of $17,298.00. Following the transaction, the insider now owns 30,019 shares of the company’s stock, valued at approximately $697,941.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Yvonne Hui also recently made the following trade(s):

• On Tuesday, July 16th, Yvonne Hui sold 283 shares of Phreesia stock. The shares were sold at an average price of $23.74, for a total value of $6,718.42.

Phreesia Stock Performance

Phreesia stock opened at $23.76 on Friday. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.03. The stock has a fifty day moving average of $23.63 and a 200 day moving average of $22.75. Phreesia, Inc. has a one year low of $12.05 and a one year high of $29.16.

Institutional Investors Weigh In On Phreesia

Several hedge funds and other institutional investors have recently made changes to their positions in PHR. Vanguard Group Inc. grew its position in Phreesia by 4.4% during the fourth quarter. Vanguard Group Inc. now owns 4,628,441 shares of the company’s stock valued at $107,148,000 after buying an additional 194,035 shares during the period. Champlain Investment Partners LLC bought a new stake in Phreesia during the 1st quarter worth approximately $29,941,000. Brown Advisory Inc. boosted its position in shares of Phreesia by 22.2% in the fourth quarter. Brown Advisory Inc. now owns 3,950,356 shares of the company’s stock worth $91,451,000 after purchasing an additional 716,374 shares during the period. Boston Partners purchased a new stake in shares of Phreesia in the first quarter worth $669,000. Finally, Blair William & Co. IL increased its stake in shares of Phreesia by 42.6% in the first quarter. Blair William & Co. IL now owns 752,700 shares of the company’s stock worth $18,012,000 after purchasing an additional 224,950 shares in the last quarter. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently commented on the stock. JMP Securities reissued a “market outperform” rating and set a $30.00 price objective on shares of Phreesia in a research report on Thursday, September 5th. Truist Financial increased their price target on shares of Phreesia from $29.00 to $31.00 and gave the company a “buy” rating in a report on Friday, September 6th. KeyCorp decreased their price objective on shares of Phreesia from $27.00 to $25.00 and set an “overweight” rating for the company in a report on Thursday, July 11th. Needham & Company LLC reiterated a “buy” rating and set a $29.00 target price on shares of Phreesia in a research note on Thursday, September 5th. Finally, DA Davidson restated a “buy” rating and issued a $32.00 price target on shares of Phreesia in a research note on Thursday, September 5th. One investment analyst has rated the stock with a hold rating and eleven have given a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $29.42.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.